Use Of Psilocybin For Mental Health Treatment ‘Not Associated’ With Risk Of Paranoia, American Medical Association Study Finds

Marijuana Moment
By Kyle JaegerApr 10, 2024, 2:14 pm289 ptsTop
Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to a new scientific review published by the American Medical Association (AMA). With increased public interest in the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Senator offers timeline for major marijuana bill 67

Texas gov. makes final hour decision on hemp ban 64

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 53

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.